Transamerica Multi-Managed Balanced Fund Common Stock

The latest common stock for IBALX is $160M as of December 2023. That compares with $160M in the prior-year period — up 0.0% year over year. Investors often review this figure alongside Transamerica Multi-Managed Balanced Fund's historical trend and sector peers before judging valuation or financial health.

Over the past year, IBALX's common stock moved from $160M to $160M — essentially flat versus a year earlier. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Transamerica Multi-Managed Balanced Fund's operating scale or balance-sheet position.

A common stock figure of $160M for IBALX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IBALX's common stock ($160M), review year-over-year change from $160M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.